News for 'Standard Clinical Pathway'

'We Are Seeing A Lot More Male Fertility Cases'

'We Are Seeing A Lot More Male Fertility Cases'

Rediff.com1 Aug 2026

Doctors attribute the rise in male infertility to obesity, diabetes, smoking, chronic stress, inadequate sleep and sedentary lifestyles.

Health Expert Cautions Against AI Self-Diagnosis

Health Expert Cautions Against AI Self-Diagnosis

Rediff.com27 Feb 2026

A senior health expert warns against the growing trend of using AI for self-diagnosis and treatment, emphasizing that these tools should not replace human clinical judgment.

Want To Pursue MBBS, PG in Germany?

Want To Pursue MBBS, PG in Germany?

Rediff.com14 Jan 2026

rediffGURU Dr Nagarajan JSK counsels a student on the possibilities and challenges of pursuing a medical residency in Germany.

Why Hospital Stays Are Getting Shorter

Why Hospital Stays Are Getting Shorter

Rediff.com3 Apr 2024

'Every hospital now tracks length of stay closely.' 'More efficiency is brought into the system now.'

Pfizer withdraws emergency use for its Covid vaccine in India

Pfizer withdraws emergency use for its Covid vaccine in India

Rediff.com5 Feb 2021

An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.

What Oncologists Should Tell You, But Seldom Do

What Oncologists Should Tell You, But Seldom Do

Rediff.com13 Nov 2023

Dear patients and caregivers, be forewarned. The disease is deadly in the truest sense. Only the mildest forms seem to be curable, and those too, if detected earlier, observes Shreekant Sambrani.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

ICMR aims to launch COVID-19 vaccine by Aug 15

ICMR aims to launch COVID-19 vaccine by Aug 15

Rediff.com3 Jul 2020

The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.

'Ayushman Bharat will be a big flop'

'Ayushman Bharat will be a big flop'

Rediff.com9 Jul 2018

'The biggest gainers under this scheme would be insurance companies.' 'If the government is going to route the payments through the insurance companies, these companies will be making nearly 30 per cent of the money.' 'For instance, if the government is paying Rs 100, then Rs 30 will go to these insurance companies.' 'Only Rs 70 will be available for expenditure that will be incurred by the hospitals.'

Why BJP Needs A Democratic Check-Up

Why BJP Needs A Democratic Check-Up

Rediff.com2 Apr 2022

The country may become militarily impressive, pile on GDP and the durbar of the ruling party may fill with the wealthy indebted to the rulers for their riches. But the spontaneous camaraderie of a free people will diminish and with it, our shared ownership of the country, warns Shyam G Menon.